The Genus Ochrobactrum as Major Opportunistic Pathogens

Microorganisms
Michael P Ryan, J Tony Pembroke

Abstract

Ochrobactrum species are non-enteric, Gram-negative organisms that are closely related to the genus Brucella. Since the designation of the genus in 1988, several distinct species have now been characterised and implicated as opportunistic pathogens in multiple outbreaks. Here, we examine the genus, its members, diagnostic tools used for identification, data from recent Ochrobactrum whole genome sequencing and the pathogenicity associated with reported Ochrobactrum infections. This review identified 128 instances of Ochrobactrum spp. infections that have been discussed in the literature. These findings indicate that infection review programs should consider investigation of possible Ochrobactrum spp. outbreaks if these bacteria are clinically isolated in more than one patient and that Ochrobactrum spp. are more important pathogens than previously thought.

References

Dec 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W R Gransden, S J Eykyn
Apr 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T J CieslakG W Fischer
Oct 1, 1987·Journal of Clinical Microbiology·W J BarsonM J Marcon
Jan 1, 1989·Journal of Clinical Microbiology·K G Van HornG P Wormser
Jun 1, 1984·Journal of Clinical Microbiology·M A KishB A Forbes
Aug 1, 1980·Journal of Clinical Microbiology·P C Appelbaum, D B Campbell
May 1, 1994·The Journal of Hospital Infection·H EzzedineJ J Haxhe
Jun 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D AlnorW Frederiksen
Sep 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F BrivetJ Dormont
Mar 1, 1996·The Journal of Infectious Diseases·H J ChangW R Jarvis
Dec 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P van DijckM J Struelens
Aug 1, 1996·American Journal of Ophthalmology·M BraunG O Naumann
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T J CieslakM L Robb
Feb 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K C EarhartM R Wallace
Apr 1, 1997·American Journal of Ophthalmology·A J BermanC K Fischer
Jul 1, 1997·Heart & Lung : the Journal of Critical Care·M V GillB A Cunha
Dec 17, 1998·Journal of Clinical Microbiology·L V MöllerM J Slooff
Mar 17, 1999·Heart & Lung : the Journal of Critical Care·N Jelveh, B A Cunha
May 26, 1999·The Journal of Infection·A J Hay, T Y Lo
Aug 6, 1999·The British Journal of Ophthalmology·K InoueY Fujino
Mar 9, 2000·The Journal of Hospital Infection·E DelièreA Bouvet
Jun 13, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G M Chertow
Jul 25, 2000·The Journal of Infection·H Peltroche-LlacsahuangaG Haase
Jun 5, 2001·The Journal of Antimicrobial Chemotherapy·C S HigginsT R Walsh
Jan 16, 2002·The Pediatric Infectious Disease Journal·Eftichia StiakakiMaria Kalmanti
Jan 19, 2002·The Journal of Infection·D El-ZimaityK Djemal
Feb 20, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Antonio MastroianniGiuseppe Montini
Mar 1, 1996·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·José M. RamosFrancisco Soriano
Aug 7, 2002·Internal Medicine Journal·L WheenK Godfrey
Sep 27, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Florian DaxboeckJosef Kovarik
Feb 13, 2003·Scandinavian Journal of Infectious Diseases·Emmanouil GalanakisYiannis Tselentis
Mar 8, 2003·Journal of Clinical Microbiology·Adrien KettanehLaurent Hocqueloux
May 2, 2003·Journal of Medical Microbiology·Ashraf A F Elsaghir, Edward A James
Jun 17, 2003·International Journal of Systematic and Evolutionary Microbiology·Peter KämpferErko Stackebrandt
Sep 6, 2003·Journal of Clinical Microbiology·Jeffrey W Oliver
Jan 16, 2004·Scandinavian Journal of Infectious Diseases·Simon Hill
Jul 10, 2004·Journal of Clinical Microbiology·M P Romero GómezP Peña García
Mar 5, 2005·Applied and Environmental Microbiology·Martha E TrujilloEncarna Velázquez
Sep 20, 2005·Diagnostic Microbiology and Infectious Disease·Anucha ApisarnthanarakLinda M Mundy

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
PCR

Software Mentioned

Microscan Walkaway
MLSA ( Multi - Locus Sequence Analysis )
RapID NF Plus
Web
Google Scholar

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Medical Microbiology : IJMM
Bryan ThomaHerbert Tomaso
Journal of Infection and Public Health
Girish KulkarniMahesh Dharne
Diagnostic Microbiology and Infectious Disease
Anucha ApisarnthanarakLinda M Mundy
© 2021 Meta ULC. All rights reserved